Last reviewed · How we verify
NCT06259630: NEVE
Nicotine Virtual Reality Conditioned Place Preference
Phase 4 trial testing Nicotine in Nicotine Addiction. Withdrawn.
22 June 2018
Quick facts
| Lead sponsor | University of Chicago |
|---|---|
| Phase | Phase 4 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | basic science |
| Start date | 3 November 2015 |
| Primary completion | 22 June 2018 |
| Estimated completion | 22 June 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Nicotine (NICOTINE) — full drug profile →
- Placebo oral capsule
Conditions studied
- Nicotine Addiction — all drugs for Nicotine Addiction →
- Nicotine Use Disorder — all drugs for Nicotine Use Disorder →
Sponsor
University of Chicago
Who can join
Adults 18 to 35, any sex, with Nicotine Addiction or Nicotine Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this between-subjects, placebo controlled, double-blind study, the investigators will examine the effects of low oral doses of nicotine on the learning and extinction of a conditioned place preference acquired in a virtual reality environment by healthy human subjects. Physiological and subjective responses to the drug will also be monitored.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06259630
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nicotine
Trials testing the same drug.
- NCT06334016 — Evaluating the Delivery and Effects of THC Vaping Liquids in the Bloodstream · EARLY_PHASE1 · not yet recruiting
- NCT05999383 — Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration · Phase 2 · recruiting
- NCT06096714 — Addictive Threshold of Nicotine · EARLY_PHASE1 · recruiting
- NCT06027723 — Nicotine and Pavlovian Bias · EARLY_PHASE1 · unknown
- NCT03634839 — Effects of E-cigarette Flavors on Youth TCORS 2.0 · Phase 1 · completed
Other recruiting trials for Nicotine Addiction
Currently open trials in the same condition.
- NCT07020273 — CONNECT Cancer Survivors With Tobacco Treatment · NA · recruiting
- NCT06803706 — Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community · NA · recruiting
- NCT06582888 — Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder · EARLY_PHASE1 · recruiting
- NCT06254001 — Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects · Phase 4 · recruiting
- NCT06471387 — Unraveling the Genetic Basis of Nicotine Addiction for Novel Therapeutic Strategies · recruiting
Other University of Chicago trials
Trials by the same sponsor.
- NCT07346196 — A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck · Phase 2 · not yet recruiting
- NCT07354100 — Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy · Phase 1, PHASE2 · not yet recruiting
- NCT06446661 — Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia · NA · not yet recruiting
- NCT07179315 — A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Tr · Phase 2 · not yet recruiting
- NCT07126561 — Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06259630 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Chicago
- Last refreshed: 14 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06259630.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing